Back

Resveratrol attenuates diastolic dysfunction by reducing cardiac fibrosis in a model of doxorubicin cardiomyopathy

21 May 2016 (08:30 - 17:30)
Organised by:
Congress Presentation Part of: Poster Session 1 - Basic Science: Cardiomyopathy Cardiomyopathies HFA Premium Access HEART FAILURE 2016

About the speaker

Photo
Doctor Donato Cappetta

Second University of Naples, Naples (Italy)

23 More presentations in this session

Presentation thumbnail
Doctor R. Gogiraju (Mainz, DE)
Abstract
Presentation thumbnail
Doctor G. Galati (Milan, IT)
Abstract Slides
Presentation thumbnail
Presentation thumbnail
Professor L. Zhang (Shanghai, CN)
Abstract
Presentation thumbnail
Professor R. Mourilhe Rocha (Rio de Janeiro, BR)
Abstract Slides

Access the full session

Session thumbnail
Poster Session 1 - Basic Science: Cardiomyopathy

The Event

Event poster

HEART FAILURE 2016

21 May 2016 08:30 CET
You may be interested in
thumbnail
Congress Presentation
Initial phase of anthracycline cardiotoxicity involves metabolic switch and activation of cardiac fibroblasts
28 August 2023
thumbnail
Congress Presentation
Echocardiographic predictors of left ventricular interstitial fibrosis in chronic primary mitral regurgitation with preserved ejection fraction: the underrecognized role of diastolic dysfunction
11 December 2024
thumbnail
Congress Presentation
Diastolic dysfunction is associated with development of heart failure in patients with breast cancer under chemotherapy
22 May 2023
thumbnail
Congress Presentation
Association of the exerkines apelin and irisin with myocardial fibrosis and cardiac dysfunction in early stages of hypertensive heart failure
22 May 2023

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources